Search results for: 'Deep Learning enterprise market validation'

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

The skyrocketing volume of medical imaging data and need to better manage medical images is becoming imperative for healthcare providers. The collaborative HIMSS-SIIM Enterprise Imaging Workgroup de?nes enterprise imaging as “a set of strategies, initiatives, and work?ows implemented across a healthcare enterprise to consistently and optimally capt...

08 Nov 2024  |  Global  |  Market Research

Growth Opportunities in Enterprise Imaging, Global, 2023-2028

Enterprise Imaging is Experiencing Transformational Growth in its Shift to a Cloud-native Software-as-a-Service Business Model with AI Integrations as a Growth Lever

Infographics

×

Medical imaging is no longer limited to radiology, and radiology software solutions are facing challenges in accessing and integrating patient data across health networks. As a result, healthcare providers are adopting enterprise imaging (EI) strategies to consolidate all patient data into a single platform to provide better access and improved dat...

This growth insights service presents an analysis of the global enterprise imaging solutions market. With healthcare systems gradually transitioning to value-based care, care providers are increasingly relying on imaging informatics systems to achieve clinical, operational, and financial excellence which are the key factors to succeed in a value-b...

01 Feb 2022  |  Global  |  Frost Radar

Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

In the cloud industry and most other technology-related industries, 2024 will be all about artificial intelligence (AI). Businesses are grappling with how they can leverage AI (particularly generative AI) to meet their goals. Public cloud providers are at the forefront of efforts to accelerate customers AI adoption by developing foundational model...

22 Apr 2022  |  Global  |  Market Research

Global Deep Brain Stimulation Growth Opportunities

Exploration of New Clinical Applications Drive Future Growth Potential

Infographics

×

Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...